Mingqiu Liu Selected Research

Mingqiu Liu Research Topics

Disease

7	Carcinogenesis 08/2003 - 03/2002
6	Neoplasms (Cancer) 01/2022 - 12/2002
5	Infections 01/2014 - 07/2004
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2003 - 03/2002
4	Lung Neoplasms (Lung Cancer) 01/2009 - 03/2002
3	Inflammation (Inflammations) 01/2023 - 07/2002
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2016 - 08/2013
3	Neoplasm Metastasis (Metastasis) 08/2003 - 03/2002
3	Carcinoma (Carcinomatosis) 06/2003 - 03/2002
2	Virus Diseases (Viral Diseases) 01/2023 - 11/2012
2	Hyperplasia 04/2006 - 06/2003
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2003 - 02/2002
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2023
1	Colitis 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Diarrhea 01/2014
1	Giardiasis 01/2014
1	Reinfection 01/2014
1	Epilepsy (Aura) 08/2013
1	Viremia 07/2007
1	Dehydration (Water Stress) 07/2007
1	Vesicular Stomatitis 11/2006
1	Lymphatic Metastasis 08/2004
1	Vascular Tissue Neoplasms 06/2003
1	Carcinoma in Situ 06/2003
1	Metaplasia 06/2003

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2009 - 03/2002
6	MethylcholanthreneIBA 01/2009 - 03/2002
3	Small Interfering RNA (siRNA)IBA 05/2010 - 07/2004
2	Valproic Acid (Depakote)FDA LinkGeneric 07/2016 - 08/2013
2	VaccinesIBA 01/2014 - 05/2010
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 08/2013 - 12/2002
2	Antiviral Agents (Antivirals)IBA 11/2006 - 07/2004
2	Iodized OilIBA 04/2006 - 03/2002
2	Messenger RNA (mRNA)IBA 08/2003 - 03/2002
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2003 - 07/2002
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 04/2003 - 07/2002
1	NF-kappa B (NF-kB)IBA 01/2023
1	cepharanthineIBA 01/2023
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2023
1	CollagenIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	pirfenidoneIBA 01/2023
1	Dextran SulfateIBA 01/2022
1	Deubiquitinating EnzymesIBA 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022
1	CytokinesIBA 01/2022
1	Histone Deacetylase InhibitorsIBA 07/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 07/2016
1	Notch ReceptorsIBA 01/2016
1	Member 2 Group A Nuclear Receptor Subfamily 4IBA 01/2016
1	Metronidazole (Metric)FDA LinkGeneric 01/2014
1	Immunoglobulin A (IgA)IBA 01/2014
1	Somatostatin Receptors (Somatostatin Receptor)IBA 08/2013
1	HaptoglobinsIBA 01/2009
1	Blood Proteins (Serum Proteins)IBA 01/2009
1	Prealbumin (Transthyretin)IBA 01/2009
1	Biomarkers (Surrogate Marker)IBA 01/2009
1	CD30 LigandIBA 01/2009
1	Immunoglobulin G (IgG)IBA 07/2007
1	Liposomes (Liposome)IBA 07/2007
1	Ribonuclease III (RNase III)IBA 05/2005
1	SurvivinIBA 08/2003
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2003
1	baysilon (polydimethylsiloxane)IBA 06/2003
1	Caspase 3 (Caspase-3)IBA 12/2002
1	EnzymesIBA 07/2002
1	Matrix Metalloproteinases (MMPs)IBA 03/2002
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 03/2002
1	Tissue Inhibitor of Metalloproteinase-2IBA 03/2002
1	DNA (Deoxyribonucleic Acid)IBA 03/2002
1	ParaffinIBA 02/2002
1	Phosphopyruvate Hydratase (Enolase)IBA 02/2002
1	SynaptophysinIBA 02/2002
1	Chromogranin AIBA 02/2002

Therapy/Procedure

1	Lung Transplantation 01/2023
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022
1	Investigational Therapies (Experimental Therapy) 11/2012
1	Lasers (Laser) 01/2009
1	Fluid Therapy (Oral Rehydration Therapy) 07/2007
1	Chemoprevention 04/2006